AIM ImmunoTech Inc (AIM)
0.195
+0.01
(+3.94%)
USD |
NYAM |
Dec 24, 16:00
AIM ImmunoTech Gross Profit (Annual): 0.16M for Dec. 31, 2023
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 42.51M |
| Electromed Inc | 41.73M |
| Xtant Medical Holdings Inc | 55.47M |
| Armata Pharmaceuticals Inc | -- |